Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125372301 | 12537230 | 1 | I | 2012 | 20151230 | 20160707 | 20160707 | PER | US-JAZZ-2015-US-022744 | JAZZ | 0.00 | M | Y | 0.00000 | 20160707 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125372301 | 12537230 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
125372301 | 12537230 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | 21196 | ORAL SOLUTION | |||||||||
125372301 | 12537230 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4 G, BID | 21196 | 4 | G | ORAL SOLUTION | |||||||
125372301 | 12537230 | 4 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
125372301 | 12537230 | 5 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | 21196 | ORAL SOLUTION | |||||||||
125372301 | 12537230 | 6 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4 G, BID | 21196 | 4 | G | ORAL SOLUTION | |||||||
125372301 | 12537230 | 7 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | 21196 | 4.5 | G | ORAL SOLUTION | |||||||
125372301 | 12537230 | 8 | SS | STRATTERA | ATOMOXETINE HYDROCHLORIDE | 1 | UNK | N | 0 | ||||||||||
125372301 | 12537230 | 9 | SS | CONCERTA | METHYLPHENIDATE HYDROCHLORIDE | 1 | UNK | N | 0 | ||||||||||
125372301 | 12537230 | 10 | C | CHOLESTYRAMINE. | CHOLESTYRAMINE | 1 | UNK | U | 0 | ||||||||||
125372301 | 12537230 | 11 | C | DICYCLOMINE | DICYCLOMINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
125372301 | 12537230 | 12 | C | PROVIGIL | MODAFINIL | 1 | UNK | U | 0 | ||||||||||
125372301 | 12537230 | 13 | C | Vitamins | VITAMINS | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125372301 | 12537230 | 1 | Narcolepsy |
125372301 | 12537230 | 8 | Product used for unknown indication |
125372301 | 12537230 | 9 | Product used for unknown indication |
125372301 | 12537230 | 10 | Product used for unknown indication |
125372301 | 12537230 | 11 | Product used for unknown indication |
125372301 | 12537230 | 12 | Product used for unknown indication |
125372301 | 12537230 | 13 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125372301 | 12537230 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125372301 | 12537230 | Epigastric discomfort | |
125372301 | 12537230 | Irritable bowel syndrome | |
125372301 | 12537230 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125372301 | 12537230 | 1 | 200809 | 200809 | 0 | |
125372301 | 12537230 | 2 | 2008 | 2009 | 0 | |
125372301 | 12537230 | 3 | 200910 | 2010 | 0 | |
125372301 | 12537230 | 4 | 201103 | 2011 | 0 | |
125372301 | 12537230 | 5 | 2011 | 2011 | 0 | |
125372301 | 12537230 | 6 | 2011 | 2012 | 0 | |
125372301 | 12537230 | 7 | 201206 | 0 | ||
125372301 | 12537230 | 8 | 20101210 | 20131210 | 0 | |
125372301 | 12537230 | 9 | 20121210 | 0 | ||
125372301 | 12537230 | 10 | 20101210 | 20131210 | 0 | |
125372301 | 12537230 | 11 | 20101210 | 20131210 | 0 | |
125372301 | 12537230 | 12 | 20101210 | 20131210 | 0 | |
125372301 | 12537230 | 13 | 20101210 | 20111210 | 0 |